Clinical Trial Update: A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 open-label study to evaluate the safety, tolerability, and efficacy of a single intravenous dose of SAR44…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• SAR444836

Snippet

Sponsor: Sanofi | Conditions: Phenylketonuria | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING